ClinicalTrials.govpublic full text
Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts
hiv-1 infection, immunosuppression-related infectious disease, naives, cd4 < 200 cell/mm3, atazanavir, darunavir, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 860046
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.